New Virginia G. Piper Cancer Center-TGen study targets small-cell lung cancer
09:38 EDT 29 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
PR610 designed to activate in cancer tissue with low levels of oxygen
SCOTTSDALE, Ariz., Aug. 29, 2012 /PRNewswire-USNewswire/ -- A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first-in-class cancer tr...
Other Sources for this Article
More From BioPortfolio on "New Virginia G. Piper Cancer Center-TGen study targets small-cell lung cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
